Category: Patent Infringement
Boston Scientific denies allegations by stents rival OrbusNeich that it tried to block the seizure of stants whose importation is banned in Germany.
The U.S. Supreme Court agrees to hear Medtronic's appeal of a patent infringement loss to rival Boston Scientific over cardiac rhythm management technology.
Globus Medical accuses Johnson & Johnson's DePuy Synthes unit of violating its patent for an intervertebral fusion implant with the Zero-P VA device.
A German court issues a 2nd injunction barring Boston Scientific from importing drug-eluting stents into that country.
The FDA clears Biolase's WaterLase iPlus tissue laser in the U.S.
Biolase (NSDQ:BIOL) won 510(k) clearance from the FDA for its WaterLase iPlus, a laser used for soft-tissue orthopedic procedures.
The clearance opens up a $2.6 billion market opportunity for the WaterLase device, according to a company statement.
Medtronic's CoreValve subsidiary asks the U.S. Supreme Court to consider its appeal of a lower court's decision to uphold a $74 million verdict in favor of Edwards Lifesciences and its Sapien heart valve.
OrbusNeich exercises its legal win by blocking the import of Boston Scientific's Promus, Taxus, Omega and Synergy stents into Germany.
OrbusNeich Medical wasted no time in enforcing a patent win against Boston Scientific (NYSE:BSX), announcing that it is blocking German imports of its rival's cardiac stents.
